Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1992 Oct;30(10):2740–2742. doi: 10.1128/jcm.30.10.2740-2742.1992

Optimum use of selective plated media in primary processing of respiratory tract specimens from patients with cystic fibrosis.

G V Doern 1, B Brogden-Torres 1
PMCID: PMC270512  PMID: 1400978

Abstract

A total of 258 respiratory tract specimens from patients with cystic fibrosis were inoculated onto nine different plated media, and the rates of recovery of potential pathogens were compared. Media included sheep blood agar, enriched chocolate agar, MacConkey agar for gram-negative bacilli, chocolate agar containing bacitracin for Haemophilus spp., bromcresol green agar for yeasts, cetrimide agar for Pseudomonas spp., sheep blood agar containing colistin and nalidixic acid for gram-positive cocci, mannitol salt agar for Staphylococcus aureus, and oxidation-fermentation agar containing 300 U of polymyxin B per ml and 2 U of bacitracin per ml (OF-PBL medium) for Pseudomonas cepacia. With two exceptions, all of these media proved useful in recovering potential pathogens from respiratory tract specimens from patients with cystic fibrosis. The two exceptions were cetrimide agar and colistin-nalidixic acid-supplemented sheep blood agar, which were found to be superfluous. In addition, the results of this study further delineated the prevalence of selected bacteria and fungi in respiratory tract secretions from patients with cystic fibrosis. In rank order of frequency of isolation, we recovered isolates of Pseudomonas aeruginosa, Haemophilus parainfluenzae, Candida albicans, S. aureus, Haemophilus influenzae, molds, members of the family Enterobacteriaceae, yeasts other than Candida albicans, miscellaneous gram-negative bacilli, beta-hemolytic streptococci, P. cepacia, and Streptococcus pneumoniae.

Full text

PDF
2740

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Black-Payne C., Lierl M. B., Bocchini J. A., Hilman B. C., Rambin E. D., Silberman R. Comparison of two selective media developed to isolate Pseudomonas cepacia from patients with cystic fibrosis. Diagn Microbiol Infect Dis. 1987 Apr;6(4):277–282. doi: 10.1016/0732-8893(87)90175-1. [DOI] [PubMed] [Google Scholar]
  2. Carson L. A., Tablan O. C., Cusick L. B., Jarvis W. R., Favero M. S., Bland L. A. Comparative evaluation of selective media for isolation of Pseudomonas cepacia from cystic fibrosis patients and environmental sources. J Clin Microbiol. 1988 Oct;26(10):2096–2100. doi: 10.1128/jcm.26.10.2096-2100.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chapin K. C., Doern G. V. Selective media for recovery of Haemophilus influenzae from specimens contaminated with upper respiratory tract microbial flora. J Clin Microbiol. 1983 Jun;17(6):1163–1165. doi: 10.1128/jcm.17.6.1163-1165.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gilligan P. H., Gage P. A., Bradshaw L. M., Schidlow D. V., DeCicco B. T. Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol. 1985 Jul;22(1):5–8. doi: 10.1128/jcm.22.1.5-8.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gilligan P. H., Gage P. A., Welch D. F., Muszynski M. J., Wait K. R. Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis. J Clin Microbiol. 1987 Jul;25(7):1258–1261. doi: 10.1128/jcm.25.7.1258-1261.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hammerschlag M. R., Harding L., Macone A., Smith A. L., Goldmann D. A. Bacteriology of sputum in cystic fibrosis: evaluation of dithiothreitol as a mucolytic agent. J Clin Microbiol. 1980 Jun;11(6):552–557. doi: 10.1128/jcm.11.6.552-557.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Maduri-Traczewski M., L'Heureux C., Escalona L., Macone A., Goldmann D. Facilitated detection of antibiotic-resistant Pseudomonas in cystic fibrosis sputum using homogenized specimens and antibiotic-containing media. Diagn Microbiol Infect Dis. 1986 Nov;5(4):299–305. doi: 10.1016/0732-8893(86)90032-5. [DOI] [PubMed] [Google Scholar]
  8. Parry M. F., Neu H. C. Effect of N-acetylcysteine on antibiotic activity and bacterial growth in vitro. J Clin Microbiol. 1977 Jan;5(1):58–61. doi: 10.1128/jcm.5.1.58-61.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Tablan O. C., Carson L. A., Cusick L. B., Bland L. A., Martone W. J., Jarvis W. R. Laboratory proficiency test results on use of selective media for isolating Pseudomonas cepacia from simulated sputum specimens of patients with cystic fibrosis. J Clin Microbiol. 1987 Mar;25(3):485–487. doi: 10.1128/jcm.25.3.485-487.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Welch D. F., Muszynski M. J., Pai C. H., Marcon M. J., Hribar M. M., Gilligan P. H., Matsen J. M., Ahlin P. A., Hilman B. C., Chartrand S. A. Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis. J Clin Microbiol. 1987 Sep;25(9):1730–1734. doi: 10.1128/jcm.25.9.1730-1734.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Wong K., Roberts M. C., Owens L., Fife M., Smith A. L. Selective media for the quantitation of bacteria in cystic fibrosis sputum. J Med Microbiol. 1984 Apr;17(2):113–119. doi: 10.1099/00222615-17-2-113. [DOI] [PubMed] [Google Scholar]
  12. Wu B. J., Thompson S. T. Selective medium for Pseudomonas cepacia containing 9-chloro-9-(4-diethylaminophenyl)-10-phenylacridan and polymyxin B sulfate. Appl Environ Microbiol. 1984 Oct;48(4):743–746. doi: 10.1128/aem.48.4.743-746.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES